Elli Lilly has chosen a location near Richmond, VA, for its planned $5 billion manufacturing plant that will be the first-ever dedicated, fully integrated active pharmaceutical ingredient (API) and ...

Novartis has agreed to partner on developing additional molecular glue degraders (MGDs) for immune-mediated diseases, in an expanded collaboration that could generate more than $5.7 billion for the ...

The reference-quality genome assembly of an experimentally relevant human cell line, retinal pigment epithelial line RPE-1, is completed.

The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.

Flexynesis uses deep learning to evaluate multi-omics data as well as specially processed texts and images, including CT or ...

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...

While biologics are expected to drive CDMO growth through 2033, foreign exchange rates and tariffs are looming challenges.

Perfect Preparation Prevents Poor Performance.” These five Ps—with maybe a sixth before the word “poor”—is a traditional saying about the need for careful planning if one wants to succeed.

As the industry adopts in-line monitoring and analytics, integrated AI-linked sensors may soon enable model-based process controls.

From operational overhauls to product design, biomanufacturing and bioprocessing companies reduce their environmental impact.

Novo Nordisk inflicted much pain—and much-needed pain—when president and CEO Maziar (Mike) Doustdar announced the company’s ...

Illusion circuits in the visual cortex were uncovered with two-photon holography, advancing perception and neurophysiology studies.